Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 108, Issue 4, Pages 826-830
Publisher
Springer Nature
Online
2013-02-15
DOI
10.1038/bjc.2013.46
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors
- (2012) A. Naing et al. CLINICAL CANCER RESEARCH
- The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cells
- (2012) Maria Cristina De Martino et al. ENDOCRINE-RELATED CANCER
- Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial
- (2012) Matthias Kroiss et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Adrenocortical stem and progenitor cells: Implications for adrenocortical carcinoma
- (2012) Derek P. Simon et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Combination Chemotherapy in Advanced Adrenocortical Carcinoma
- (2012) Martin Fassnacht et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase I Trial of Cixutumumab Combined with Temsirolimus in Patients with Advanced Cancer
- (2011) Aung Naing et al. CLINICAL CANCER RESEARCH
- Targeted Therapies for Adrenocortical Carcinoma: IGF and Beyond
- (2011) Michael J. Demeure et al. Hormones & Cancer
- Regulation of Insulin-like Growth Factor–Mammalian Target of Rapamycin Signaling by MicroRNA in Childhood Adrenocortical Tumors
- (2010) Mabrouka Doghman et al. CANCER RESEARCH
- Recurrence of Adrenal Cortical Carcinoma Following Resection: Surgery Alone Can Achieve Results Equal to Surgery Plus Mitotane
- (2009) Elizabeth G. Grubbs et al. ANNALS OF SURGICAL ONCOLOGY
- Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma
- (2009) Paul Haluska et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Prevalence and Incidence of Endocrine and Metabolic Disorders in the United States: A Comprehensive Review
- (2009) Sherita H. Golden et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma
- (2008) Martin Fassnacht et al. CANCER
- Expression of Insulin-Like Growth Factor-II and Its Receptor in Pediatric and Adult Adrenocortical Tumors
- (2008) Madson Q. Almeida et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Preclinical Targeting of the Type I Insulin-Like Growth Factor Receptor in Adrenocortical Carcinoma
- (2008) Ferdous M. Barlaskar et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started